Loading comparison data...
Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare Lasmiditan (Reyvow) and Ubrogepant (Ubrelvy) — clinical data, side effects, and patient experiences.
Reyvow · 5-HT1F Agonist (Ditan)
How it works
Selective 5-HT1F receptor agonist that inhibits trigeminal nerve firing without vasoconstriction, unlike triptans.
Approved for
Ubrelvy · CGRP Antagonist (Gepant)
How it works
Oral CGRP receptor antagonist for acute migraine treatment without vasoconstrictive properties of triptans.
Approved for
Estimated frequency (%) based on clinical trial data
Based on 7 Reddit discussions
Lasmiditan
86%
positive
7 threads
Ubrogepant
0%
positive
0 threads
% of discussions mentioning each side effect
7 Reddit threads analysed for Lasmiditan
Overall Sentiment
Slightly positive
Comparison Threads
0
Avg Post Score
66 upvotes
Most discussed side effects in community
I’ve had migraines since I was 4 years old (I’m 31 now). Daily or near-daily, severe, and completely life-disrupting. I’ve tried everything: * All major preventives * Botox every 10–12 weeks * Triptans (including years of nightly Relpax) * Lasmiditan almost daily * CGRPs * all types of Beta blockers
Hello! I've been in status migrainosus for about 90 days now and I don't know what to do. I'm currently on 75mg Topiramate to see if that can break my status. I was given Prednisolone at the ER for a couple of days, but that did not help. My condition has improved since I started the medication, but
Hi everyone! So I’ve been prescribed lasmiditan for my migraines and my doctor said that’s it’s a newer medication for them. I’m just wondering who, if anyone, if taking it? So far it’s been helpful and it’s just been 50ng but I got it bumped up to 100mg. I started usuing it in January and everytime
The Global and United States **Lasmiditan Succinate** Market Report was published by QY Research recently. **Lasmiditan Succinate** **Market Analysis and Insights** This report focuses on global and United States Lasmiditan Succinate market, also covers the segmentation data of other regions in regi
The Global and United States **Lasmiditan Hemisuccinate** Market Report was published by QY Research recently. **Lasmiditan Hemisuccinate** **Market Analysis and Insights** This report focuses on global and United States Lasmiditan Hemisuccinate market, also covers the segmentation data of other reg
Migraines are a complex and debilitating neurological disorder affecting millions worldwide. Characterized by intense, often unilateral headaches accompanied by symptoms such as nausea, vomiting, and sensitivity to light and sound, migraines can significantly impair daily functioning and quality of
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
No community discussions found for Ubrogepant yet.
Lasmiditan is a 5-HT1F Agonist (Ditan), while Ubrogepant belongs to the CGRP Antagonist (Gepant) class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles.
Both medications are approved for Acute Migraine. When two drugs treat the same condition, the choice between them often depends on the patient's medical history, other medications, tolerability, and prescriber preference.
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.